NMTC Stock Analysis: Buy, Sell, or Hold?
NMTC - NeuroOne Medical Technologies Corporation Common Stock
$0.92
-0.06 (-6.19%)
âŧ
5d:
-4.38%
30d:
-30.88%
90d:
-47.77%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Dec 15, 2026
Get Alerted When NMTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NMTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NMTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NMTC is currently trading at $0.92, which is considered slightly low relative to its 30-day fair value range of $1.01 to $1.34.
Technical Outlook: Technically, NMTC is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.14. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: NMTC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.27 (+690.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NMTC is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.14. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: NMTC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.27 (+690.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.01 -
$1.34
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 690.5% below Wall St target ($7.27)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.01 -
$1.34
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.88
Resistance Level
$1.14
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.45
Wall Street Target
$7.27
(+690.5%)
Revenue Growth (YoY)
16.3%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: October 24, 2026 6:22 AM ET
Data refreshes hourly during market hours. Next update: 7:22 AM
Data refreshes hourly during market hours. Next update: 7:22 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
